BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 19256247)

  • 1. [Routine platelet aggregation inhibition not useful when using acetylsalicylic acid or clopidogrel].
    Kramer MC; Nieuwland R; Sturk A; de Winter RJ
    Ned Tijdschr Geneeskd; 2009 Jan; 153(5):190-5. PubMed ID: 19256247
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin and clopidogrel resistance-a myth or reality: an update.
    Gupta S; Gupta MM
    Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315
    [No Abstract]   [Full Text] [Related]  

  • 3. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 4. Clopidogrel but not Aspirin prevents acute smoking-induced platelet aggregation in patients with stable coronary artery disease.
    Addad F; Chakroune T; Asma A; Abderazek F; Zohra D; Ghrissi I; Hassine M; Gamra H; Elalamy I
    Thromb Res; 2009 Feb; 123(4):640-3. PubMed ID: 18602138
    [No Abstract]   [Full Text] [Related]  

  • 5. Clopidogrel resistance.
    Oqueli E; Hiscock M; Dick R
    Heart Lung Circ; 2007; 16 Suppl 3():S17-28. PubMed ID: 17611155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin and clopidogrel resistance: an emerging clinical entity.
    Wang TH; Bhatt DL; Topol EJ
    Eur Heart J; 2006 Mar; 27(6):647-54. PubMed ID: 16364973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
    Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
    Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "clopidogrel resistance" trap.
    Serebruany VL
    Am J Cardiol; 2007 Sep; 100(6):1044-6. PubMed ID: 17826395
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacology of ticlopidine and clopidogrel in comparison with acetylsalicylic acid].
    Weber AA; Schrör K
    Internist (Berl); 1997 Nov; 38(11):1115-20; discussion 1120. PubMed ID: 9453968
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease.
    Kim H; Lee HK; Han K; Jeon HK
    Ann Clin Lab Sci; 2009; 39(3):289-94. PubMed ID: 19667414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].
    Mani H; Lindhoff-Last E
    Pharm Unserer Zeit; 2009; 38(4):342-50. PubMed ID: 19572355
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of unresponsiveness to aspirin and/or clopidogrel in patients with stable coronary heart disease.
    Lordkipanidzé M; Diodati JG; Schampaert E; Palisaitis DA; Pharand C
    Am J Cardiol; 2009 Nov; 104(9):1189-93. PubMed ID: 19840560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin reduces the antiplatelet effect of clopidogrel.
    Lindvall G; Sartipy U; Bjessmo S; Svenarud P; Lindvall B; van der Linden J
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):178-81. PubMed ID: 19477870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durability of platelet inhibition by clopidogrel.
    Gurbel PA; Bliden KP
    Am J Cardiol; 2003 May; 91(9):1123-5. PubMed ID: 12714161
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance.
    Cattaneo M
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):1980-7. PubMed ID: 15388526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clopidogrel: new indication. In combination with aspirin: marginal additional benefits.
    Prescrire Int; 2007 Aug; 16(90):146. PubMed ID: 17724837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
    Sibbing D; Braun S; Morath T; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
    J Am Coll Cardiol; 2009 Mar; 53(10):849-56. PubMed ID: 19264241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel: mechanisms of action and review of the evidence relating to use during skin surgery procedures.
    Stewart LC; Langtry JA
    Clin Exp Dermatol; 2010 Jun; 35(4):341-5. PubMed ID: 19874336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregation and recruitment with aspirin-clopidogrel therapy.
    Helgason CM; Grossi E; Pandey D; Valika A; Cursio J; Brace LD
    Cerebrovasc Dis; 2008; 25(5):392-400. PubMed ID: 18349532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of variability in antiplatelet agents response.
    Cattaneo M
    Thromb Res; 2012 Oct; 130 Suppl 1():S27-8. PubMed ID: 23026654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.